Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Contract Research And Manufacturing Services (CRAMS) Market Heading Into 2029?

Over the recent years, a consistent expansion has been observed in the size of the spine biologics market. The market is set to increase from $2.36 billion in 2024 to $2.47 billion in 2025, showing a compound annual growth rate (CAGR) of 4.8%. This augmentation witnessed in the historical time-frame can be accredited to advancements in biotech, a rising elderly populace, the growing occurrence of spinal disorders, a surging preference for less invasive medical procedures, an escalated consciousness about spinal wellbeing, advancements in diagnosis methods, and improved healthcare infrastructure.

The market size for spine biologics is predicted to experience substantial growth in the coming years, expanding to “$3.03 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This forthcoming growth in the projection period can be credited to advancements in technology, the rising use of regenerative medicine, higher investments in research and development, the increasing occurrence of obesity and inactive lifestyles, improved healthcare access in developing markets, beneficial regulatory sanctions, and greater industry collaborations and partnerships. Key trends for the projection period encompass the appearance of new regenerative treatments, the incorporation of artificial intelligence in treatment mapping, the spread of personalized medicine strategies, the use of 3D printing for tailor-made implants, and the creation of bioengineered scaffolds for superior tissue regeneration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15928&type=smp

Which Factors Are Pushing The Contract Research And Manufacturing Services (CRAMS) Market Forward?

The anticipated upsurge in the elderly population, along with a variety of chronic illnesses, is predicted to positively affect the expansion of the contract research and manufacturing services (CRAMS) market during the forecast period. The global elderly population is expanding swiftly and is projected to keep increasing throughout the prediction timeframe. As the aged population increases, so will the incidence of various health conditions such as cancer, diabetes, Alzheimer’s, arthritis, and other diseases, spiking the demand for diverse medications. Consequently, the requirement for contract research and manufacturing services will rise. To illustrate, the Australian Bureau of Statistics, a statistical agency based in Australia, reported that in September 2023, Australia’s population, which stood at 26 million in 2022, is foreseen to surge to anywhere from 34.3 million and 45.9 million by 2071. Additionally, the median age, which is presently 38.5 years, is expected to rise to between 43.8 and 47.6 years. Hence, the growth in the ageing population will propel the expansion of contract research and manufacturing services (CRAMS) market.

The spine biologics market covered in this report is segmented –

1) By Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy

2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types

3) By Application: Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications

4) By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users

Subsegments:

1) By Bone Allografts: Fresh Allografts, Freeze-Dried Allografts

2) By Bone Graft Substitute: Synthetic Bone Grafts, Demineralized Bone Matrix (DBM), Calcium Phosphate-Based Grafts, Platelet Rich Plasma (PRP)

3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate, Bone Marrow Concentrates

What Upcoming Trends Are Expected To Impact The Contract Research And Manufacturing Services (CRAMS) Market Globally?

Leading firms in the spinal biologics sector are pioneering innovative products like synthetic bioactive bone grafts to better cater to patient needs and attain a competitive advantage in the market. A synthetic bioactive bone graft is an artificial spine biologic designed to promote and facilitate bone growth and healing during spinal fusion surgeries. For example, in February 2022, Orthofix Medical Inc., a U.S.-based spine and orthopedics firm, launched Opus BA, a synthetic bioactive bone graft used predominantly in cervical and lumber spine fusion processes. Available in putty and strip formats, Opus BA offers a framework for bone growth which is later absorbed and replaced by natural bone. It can be moistened with autogenous bone marrow or autografted with saline. Opus BA incorporates a carbonate apatite bone mineral, bioactive glass, and Type 1 collagen osteoconductive matrix, which encourages bone growth and breakdown.

Which Organizations Are Driving Progress In The Contract Research And Manufacturing Services (CRAMS) Industry?

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc., Aziyo Biologics, Amedica Corporation

https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Contract Research And Manufacturing Services (CRAMS) Industry?

North America was the largest region in the spine biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15928&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model